↓ Skip to main content

Cochrane Database of Systematic Reviews

Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease

Overview of attention for article published in Cochrane database of systematic reviews, November 2013
Altmetric Badge

Mentioned by

blogs
1 blog
twitter
12 tweeters
facebook
1 Facebook page
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
65 Dimensions

Readers on

mendeley
167 Mendeley
citeulike
1 CiteULike
Title
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
Published in
Cochrane database of systematic reviews, November 2013
DOI 10.1002/14651858.cd002309.pub4
Pubmed ID
Authors

Chong, Jimmy, Leung, Bonnie, Poole, Phillippa

Abstract

Chronic obstructive pulmonary disease (COPD) is associated with cough, sputum production or dyspnoea and a reduction in lung function, quality of life and life expectancy. Apart from smoking cessation, there are no other treatments that slow lung function decline. Roflumilast and cilomilast are oral phosphodiesterase 4 (PDE4) inhibitors proposed to reduce the airway inflammation and bronchoconstriction seen in COPD.

Twitter Demographics

The data shown below were collected from the profiles of 12 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 167 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 1%
United States 1 <1%
Italy 1 <1%
Unknown 163 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 38 23%
Researcher 27 16%
Student > Postgraduate 14 8%
Student > Bachelor 14 8%
Other 12 7%
Other 29 17%
Unknown 33 20%
Readers by discipline Count As %
Medicine and Dentistry 58 35%
Psychology 22 13%
Nursing and Health Professions 11 7%
Social Sciences 10 6%
Engineering 4 2%
Other 16 10%
Unknown 46 28%